BCRX - Biocryst Pharmaceuticals Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - BCRX (882796)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
26 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-06-24
BCRXMcKee Amy EDirS - Sale$6.32-8,60027,831-24%-$54,352
2024-06-17
BCRXSanders MachelleDirS - Sale$6.00-4,68927,742-14%-$28,134
D
2024-06-14
BCRXHeggie TheresaDirS - Sale+OE$6.11-6,69852,852-11%-$40,925
2024-05-30
BCRXLevin Alan GDirP - Purchase$6.36+7,86144,951+21%+$49,996
2024-05-24
BCRXAselage SteveDirP - Purchase$6.40+2,50065,839+4%+$16,000
2024-05-20
BCRXHutson Nancy JDirP - Purchase$6.38+5,00086,818+6%+$31,900
2024-05-20
BCRXMilano VincentDirP - Purchase$6.25+15,00066,997+29%+$93,750
2024-05-14
BCRXDoyle AnthonyCFOP - Purchase$5.57+36,300266,744+16%+$202,191
2024-05-14
BCRXThackray Helen M.Chief R, D OfficerP - Purchase$5.86+30,000272,139+12%+$175,800
2024-05-13
BCRXGalson Steven KDirP - Purchase$5.49+21,94051,551+74%+$120,451
2024-05-13
BCRXBarnes Alane PGCP - Purchase$5.53+5,000300,762+2%+$27,650
2024-05-13
BCRXStonehouse Jon PPres, CEOP - Purchase$5.55+30,0001,167,770+3%+$166,500
2024-05-13
BCRXGayer Charles KChief Commercial OfficerP - Purchase$5.47+30,000307,533+11%+$164,100
D
2023-06-15
BCRXSanders MachelleDirS - Sale+OE$7.98-4,00025,611-14%-$31,920
D
2023-06-14
BCRXHutson Nancy JDirS - Sale+OE$8.04-12,86681,818-14%-$103,443
2023-04-03
BCRXThackray Helen M.Chief R, D OfficerS - Sale$8.29-7,000207,275-3%-$58,030
D
2023-02-01
BCRXStonehouse Jon PPres, CEOS - Sale+OE$10.38-100,0001,028,739-9%-$1,038,000
2022-12-15
BCRXStonehouse Jon PPres, CEOS - Sale$10.90-14,100897,730-2%-$153,690
2022-12-15
BCRXThackray Helen M.Chief R, D OfficerS - Sale$10.89-3,125133,275-2%-$34,031
2022-12-15
BCRXDoyle AnthonyCFOS - Sale$10.90-5,700163,966-3%-$62,130
2022-12-15
BCRXGayer Charles KChief Commercial OfficerS - Sale$10.90-6,100211,610-3%-$66,490
2022-12-15
BCRXJones Michael LExec. Dir, Finance - PAOS - Sale$10.90-44510,753-4%-$4,851
2022-12-15
BCRXBarnes Alane PGCS - Sale$10.88-4,175198,770-2%-$45,424
D
2022-12-01
BCRXJones Michael LExec. Dir, Finance - PAOS - Sale+OE$13.01-8,60011,198-43%-$111,886
DM
2022-12-01
BCRXStonehouse Jon PPres, CEOS - Sale+OE$12.94-297,573911,830-25%-$3,851,918
D
2022-11-14
BCRXBabu Yarlagadda SChief Discovery OfficerS - Sale+OE$13.88-31,515298,541-10%-$437,428

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top